A common form of weight-loss surgery may cut the risk of colorectal cancer by altering levels of molecules called bile acids in the blood and small intestine. The findings could lead to new treatments ...

AstraZeneca’s Imfinzi is adding yet another landmark perioperative label to its belt with a new FDA approval that gives the drug the title of the first and only immunotherapy marketed to treat ...

Scotland has become the first part of the UK to approve a new treatment hailed as “cutting edge care” for patients with advanced stomach cancer. The Scottish Medicines Consortium (SMC) has given the ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves endoscopy, imaging, laparoscopy, and molecular testing for markers like HER2 ...

Early-onset gastrointestinal (GI) cancers are climbing among those younger than 50 years, in the US and globally. Although colorectal cancer accounts for approximately half of such cases, rates are ...